The study's objective is to come up with a description of the international financial ecosystem surrounding the development of novel medicines (R&D). This entails charting the types of public and private players involved in research and development of medicines, ascertaining how the research agenda is prepared, establishing the strategies, mechanisms, incentives and drivers of the actors, including investors, as well as how national and international funding for new medicines (including investments and disinvestments, returns, etc.) is shaped.
[Services]
27/08/2020 10:00:00
73000000-2 Serviços de investigação e desenvolvimento e serviços de consultoria conexos
73110000-6 Serviços de investigação
73200000-4 Serviços de consultoria em matéria de investigação e desenvolvimento
79311400-1 Serviços de investigação económica
71620000-0 Serviços de análise
66170000-2 Serviços de consultoria financeira, de processamento de transacções financeiras e das câmaras de compensação
[Notice] | [DispatchDate] |
---|---|
[TNV3F02ContractNotice] ([TenderNedV3]) | 29/04/2020 16:00 |
![]() |
24/06/2020 13:23 |
[TNV3F03ContractAwardNotice] ([TenderNedV3]) | 21/07/2021 16:30 |